Oceantech Acquisitions I (OTEC) Return on Equity ROE from the first quarter 2024 to first quarter 2023 and annually, average high and low, overall ranking from Mar 31 2024 to Mar 31 2023 - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Oceantech Acquisitions I Corp   (NASDAQ: OTEC)

Oceantech Acquisitions I 's ROE per quarter

Return on Equity, Quarterly Results, Trends, Rankings, Statistics


What is ROE for Oceantech Acquisitions I in the first quarter 2024?
Due to the lack of equity, it was not possible to calculate Oceantech Acquisitions I Corp 's return on equity (ROE) in its first quarter 2024

What is ROE?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Equity (Mar 31 2024)
I. Quarter		 (Dec 31 2023)
IV. Quarter		 (Sep 30 2023)
III. Quarter		 (Jun 30 2023)
II. Quarter		 (Mar 31 2023)
I. Quarter
Y / Y Equity Change - - - - -
Y / Y Net Income Change - - - - -
Net Income (TTM) in Millions -3 -2 -107 -107 -4
Return On Equity (TTM) - - - - -
OTEC's Total Ranking # # # # #
Equity (TTM) in Millions -13 -11 -11 -10 -10
Seq. Equity Change - - - - -
Seq. Net Income Change - - - - -

Back to OTEC Management Effectiveness >> OTEC's 5 Years Annual ROE >> Compare OTEC ROE to its Competitors
Return On Equity Company Ranking
Within: No.
Industry #
Sector #
Overall #

Return On Equity Statistics
High Average Low
0 %
0 %
0 %
 





OTEC Annual Return On Equity (Dec 31 2023)
2023		 (Dec 31 2022)
2022


Total Equity in Millions -11 -8 -13 -8 0
Y / Y Equity Change - - - - -
Net Income in Millions -2 2 0 0 0
Y / Y Net Income Change - - - - -
Return On Equity - - - - -

Back to OTEC Management Effectiveness >> OTEC's 5 Years Annual ROE >> Compare OTEC ROE to its Competitors




More Return On Equity Ratios
Medical Equipment & Supplies Industry Roe Trends and Statistics
Healthcare Sector Return On Equity Statistics
OTEC's' Return on Equity at Yahoo Finance
OTEC's Roe Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and overall Market
Highest Ranking Return On Equity
Lowest Ranking Return On Equity
Subscribers only: Roe for OTEC's Competitors
Subscribers only: Roe for Oceantech Acquisitions I 's Suppliers
Subscribers only: Return On Equity for OTEC's Customers




Companies with similar Return On Equity at Mar 31 2024, within Healthcare Sector ROE
Scienture Holdings Inc   66.82 %
Idexx Laboratories Inc  63.66 %
Waters Corporation  63.25 %
Enzo Biochem Inc  61.16 %
Lantheus Holdings Inc   61.14 %
Medpace Holdings Inc   59.74 %
Amgen Inc   58.59 %
Abbvie Inc   55.25 %
Nrc Health  54.83 %
Johnson and Johnson  53.73 %
Eli Lilly And Company  53.13 %
Siga Technologies Inc  51.97 %
Elite Pharmaceuticals Inc   49.73 %
Zoetis Inc   48.39 %
Lite Strategy Inc   48.32 %
Collegium Pharmaceutical Inc   46.81 %
Protagonist Therapeutics inc   43.42 %
Kewaunee Scientific Corporation  42.26 %
Earth Science Tech Inc   41.28 %
Puma Biotechnology Inc   35.43 %
Insulet Corporation  34.86 %
Baxter International Inc   34.85 %
Star Equity Holdings Inc   34.71 %
Alkermes Plc   34.12 %
Prestige Consumer Healthcare Inc   31.73 %
Alaunos Therapeutics Inc   31.61 %
Agilent Technologies inc   30.63 %
Bruker Corporation  30.39 %
Semler Scientific inc   30.36 %
Spero Therapeutics Inc   30.04 %

Date modified: 2026-09-12T06:25:12+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.